Share the post "Choksi Laboratories : Q4 2024 Financial Quarterly Report : YoY Sales Up 14.71 %, QoQ Up 26.44 %"
Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 14.71 % in the past year, substantial increase in net sales/revenue by 26.44 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -40 %, Marginal decrease of % in other income during this quarter.
- Profit over the Year and quarter: Challenges in sustaining profitability for Choksi Laboratories Ltd.. Profit dropped by -77.13 % Year to Year, Choksi Laboratories Ltd.’s profitability increased by 1001.61 % in this quarter.
- EPS over the Year and quarter: EPS declined by -77.16 % Year to Year. EPS increased by 988.89 % in previous quarter. Positive impact on shareholders.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 9.694 Cr | Rs. 8.795 Cr | Rs. 11.12 Cr | + 26.44 % | + 14.71 % |
Expenses | Rs. 6.31 Cr | Rs. 6.56 Cr | Rs. 7.64 Cr | + 16.46 % | + 21.08 % |
Operating Profit | Rs. 3.38 Cr | Rs. 2.24 Cr | Rs. 3.48 Cr | + 55.36 % | + 2.96 % |
OPM % | 34.87 % | 25.47 % | 31.29 % | + 5.82 % | -3.58 % |
Other Income | Rs. 0.1 Cr | Rs. 0 Cr | Rs. 0.06 Cr | 0 % | -40 % |
Interest | Rs. 0.94 Cr | Rs. 0.67 Cr | Rs. 0.77 Cr | + 14.93 % | -18.09 % |
Depreciation | Rs. 1.43 Cr | Rs. 1.43 Cr | Rs. 1.49 Cr | + 4.2 % | + 4.2 % |
Profit before tax | Rs. 1.11 Cr | Rs. 0.14 Cr | Rs. 1.28 Cr | + 814.29 % | + 15.32 % |
Tax % | 11.42 % | 57.53 % | 46.93 % | -10.6 % | + 35.51 % |
Net Profit | Rs. 2.99 Cr | Rs. 0.06 Cr | Rs. 0.68 Cr | + 1033.33 % | -77.26 % |
EPS in Rs | Rs. 4.29 | Rs. 0.09 | Rs. 0.98 | + 988.89 % | -77.16 % |
Today, we’re looking at Choksi Laboratories Ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 14.71 %. However, it did see a marginal increase of 26.44 % from the previous quarter. Expenses ticked up slightly by 16.46 % quarter-on-quarter, aligning with the annual rise of 21.08 %. Operating profit, while up 2.96 % compared to last year, faced a quarter-on-quarter increase of 55.36 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -3.58 %, but an expansion of 5.82 % sequentially. despite an annual decline of -40 %. Interest expenses surged remarkably by 14.93 % from the previous quarter, yet the year-over-year decrease remains at a moderate -18.09 %. Depreciation costs climbed by 4.2 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 4.2 %. Profit before tax grew annually by 15.32 % but saw an increase from the preceding quarter by 814.29 %.
Tax expenses as a percentage of profits increased slightly by 35.51 % compared to last year, with a more notable quarter-on-quarter decrease of -10.6 %. Net profit fell by -77.26 % year-on-year but experienced a 1033.33 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -77.16 % but a quarterly rise of 988.89 %. In summary, Choksi Laboratories Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 9.694 Cr | Rs. 8.795 Cr | Rs. 11.12 Cr | + 26.44 % | + 14.71 % |
Expenses | Rs. 6.31 Cr | Rs. 6.56 Cr | Rs. 7.64 Cr | + 16.46 % | + 21.08 % |
Operating Profit | Rs. 3.38 Cr | Rs. 2.24 Cr | Rs. 3.48 Cr | + 55.36 % | + 2.96 % |
Net Profit | Rs. 2.99 Cr | Rs. 0.06 Cr | Rs. 0.68 Cr | + 1033.33 % | -77.26 % |
EPS in Rs | Rs. 4.29 | Rs. 0.09 | Rs. 0.98 | + 988.89 % | -77.16 % |
In reviewing Choksi Laboratories Ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 14.71 % year-on-year growth, however, there was a minor increase of 26.44 % from the previous quarter. Expenses rose by 21.08 % compared to the previous year, with a 16.46 % increase quarter-on-quarter. Operating Profit surged by 2.96 % annually, and saw a 55.36 % increase from the last quarter.
Net Profit showed yearly decrease of -77.26 %, and experienced a 1033.33 % increase from the previous quarter. Earnings Per Share (EPS) fell by -77.16 % annually, however rose by 988.89 % compared to the last quarter. In essence, while Choksi Laboratories Ltd. faces strong annual decline indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.